FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Ibutilide Fumarate Injection
Status: Currently in Shortage
»Date first posted: 04/29/2022
»Therapeutic Categories: Cardiovascular

Expand all

Mylan Institutional, a Viatris company (New 04/29/2022)

Company Contact Information:
800-796-9526

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 mg/10 mL (0.1 mg/mL), single dose vial (NDC 67457-366-10) Resupply June/July 2022 Other

Pfizer Pharmaceuticals (Revised 05/10/2022)

Company Contact Information:
844-646-9526

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 mg/10 mL (0.1 mg/mL), single dose vial (NDC 0009-3794-01) Available Other
1 mg/10 mL (0.1 mg/mL), single dose vial (NDC 0009-3794-22), Novaplus Next Delivery and Estimated Recovery: May 2022 Shortage per Manufacturer: Manufacturing Delay Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English